spot_img
24.7 C
London
HomeTOP STORIESAstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat

AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

spot_img

latest articles

explore more